Add time:09/03/2019         Source:sciencedirect.com

BackgroundThere is evidence regarding the abuse potential of buprenorphine in prison settings. There is also emerging evidence from community settings that buprenorphine/naloxone is less amenable to abuse than the single preparation buprenorphine hydrochloride as evidenced by cost-differentials of diverted medication. This study sought to explore cost-differentials within a prison setting of diverted buprenorphine/naloxone medication relative to either single preparation buprenorphine hydrochloride or methadone.

We also recommend Trading Suppliers and Manufacturers of buprenorphine hydrochloride (cas 136232-95-6). Pls Click Website Link as below: cas 136232-95-6 suppliers